IP Library › Assignment 017240/0865
Patent Assignment
Reel/Frame 017240/0865

Merger and Change of Name

Recorded: 2005-11-30 Pages: 14
Assignor
HYBRIDON, INC
Executed: 2005-09-12
Assignee
IDERA PHARMACEUTICALS, INC
345 VASSAR STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (64)
Modulation of Immunostimulatory Properties by Small Oligonucleotide-Based Compounds
Stabilized Immunomodulatory Oligonucleotides
Synergistic Stimulation of the Immune System Using Immunostimulatory Oligonucleotides and/or Immunomer Compounds in Conjugation with Cytokines and/or Chemotherapeutic Agents of Radiation Therapy
Hybridization Based Fluorescence Assay
Immunostimulatory Oligonucleotide Multimers
Dymnamic Wireless Broadcast System and Method for Operating the Same
Antisense Oligonucleotide Inhibition of Vascular Endothelial Growth
Patent: 6,410,322 →
Application: 08/098,942 →
Inhibition of Neovasuclarization Using Vegf-Specific Oligonucleotides
Patent: 5,731,294 →
Application: 08/378,860 →
Human Vegf-Specific Oligonucleotides
Patent: 5,639,872 →
Application: 08/398,945 →
Oligonucleotides Specific for Hepatitis B Virus
Patent: 5,856,459 →
Application: 08/468,352 →
Hpv-Specific Oligonucleotides
Patent: 6,509,149 →
Application: 08/471,974 →
Publication: US 2002/0068820
Inhibition of Neovascularization Using Vegf-Specific Oligonucleotides
Patent: 5,814,620 →
Application: 08/501,356 →
Inhibition of Neovascularization Using Vegf-Specific Oligonucleotides
Patent: 5,801,156 →
Application: 08/501,626 →
Inhibition of Neovascularization Using Vegf-Specific Oligonucleotides
Patent: 5,710,136 →
Application: 08/501,713 →
Human Vegf-Specific Oligonucleotides
Patent: 5,661,135 →
Application: 08/501,779 →
Human Vegf-Specific Oligonucleotides
Patent: 5,639,736 →
Application: 08/502,185 →
Modified Vegf Oligonucleotides
Patent: 5,641,756 →
Application: 08/569,926 →
Modified Vegf Oligonucleotides for Treatment of Skin Disorders
Patent: 6,306,829 →
Application: 08/761,708 →
Oligonucleotide Mediated Specific Cytokine Induction and Reduction of Tumor Growth in a Mammal
Patent: 6,426,334 →
Application: 08/848,229 →
Hpv-Specific Oligonucleotides
Patent: 6,458,940 →
Application: 08/887,497 →
Publication: US 2001/0010899
Oligonucleotides Specific for Hepatitis B Virus
Patent: 6,984,729 →
Application: 08/901,612 →
Ribozymes Having 2'-0 Substituted Nucleotides in the Flanking Sequences
Patent: 6,204,027 →
Application: 08/987,032 →
MDM2-Specifc Antisense Oligonucleotides
Patent: 6,013,786 →
Application: 09/073,567 →
Modified Vegf Oligonucleotides for Inhibition of Tumor Growth
Patent: 6,649,596 →
Application: 09/124,304 →
Modified Vegf Oligonucleotides
Patent: 6,399,586 →
Application: 09/320,911 →
MDM2-Specific Antisense Oligonucleotides
Patent: 6,946,447 →
Application: 09/541,848 →
Publication: US 2003/0119765
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 6,476,000 →
Application: 09/639,250 →
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 6,815,429 →
Application: 09/770,602 →
Publication: US 2002/0055475
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 7,115,579 →
Application: 09/845,623 →
Publication: US 2002/0132995
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 7,262,286 →
Application: 09/965,116 →
Publication: US 2002/0137714
Hpv Specific Oligonucleotides
Application: 10/136,427 →
Publication: US 2003/0055240
Oligonucleotide Mediated Specific Cytokine Induction and Prophylaxis and Treatment of Viral Infection in a Mammal
Patent: 7,700,570 →
Application: 10/167,825 →
Publication: US 2002/0151518
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
Patent: 7,276,489 →
Application: 10/279,684 →
Publication: US 2004/0097719
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 7,329,648 →
Application: 10/314,647 →
Publication: US 2003/0186912
Short Immunomodulatory Oligonucleotides
Patent: 7,354,907 →
Application: 10/361,111 →
Publication: US 2004/0156825
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 7,176,296 →
Application: 10/365,834 →
Publication: US 2003/0212029
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Patent: 7,105,495 →
Application: 10/406,015 →
Publication: US 2003/0236211
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 8,716,253 →
Application: 10/694,075 →
Publication: US 2004/0266709
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 7,790,168 →
Application: 10/694,207 →
Publication: US 2006/0135454
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 8,030,462 →
Application: 10/694,383 →
Publication: US 2004/0266710
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 7,824,696 →
Application: 10/694,418 →
Publication: US 2005/0026858
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Patent: 7,932,367 →
Application: 10/694,586 →
Publication: US 2006/0142224
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Utilizing Modified Immunostimulatory Dinucleotides
Patent: 7,851,453 →
Application: 10/757,345 →
Publication: US 2004/0198685
Synergistic Treatment of Cancer Using Immunomers in Conjunction with Therapeutic Agents
Patent: 7,569,554 →
Application: 10/846,167 →
Publication: US 2005/0009773
Modulation of Immunostimulatory Properties by Small Oligonucleotide-Based Compounds
Patent: 7,713,535 →
Application: 10/852,598 →
Publication: US 2005/0130918
Stabilized Immunomodulatory Oligonucleotides
Patent: 8,008,267 →
Application: 10/865,245 →
Publication: US 2005/0026861
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
Application: 10/892,550 →
Publication: US 2006/0074040
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
Patent: 7,407,944 →
Application: 10/925,872 →
Publication: US 2006/0019909
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
Patent: 7,517,862 →
Application: 10/925,873 →
Publication: US 2007/0173469
Hybridization-based fluorescence assay
Application: 10/974,129 →
Publication: US 2005/0089915
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
Application: 11/060,228 →
Publication: US 2005/0222072
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
Application: 11/078,654 →
Publication: US 2005/0266015
Immunostimulatory oligonucleotide multimers
Application: 11/153,054 →
Publication: US 2006/0014713
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Utilizing Modified Immunostimulatory Dinucleotides
Patent: 7,595,305 →
Application: 11/173,794 →
Publication: US 2006/0287261
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Utilizing Modified Immunostimulatory Dinucleotides
Patent: 7,632,822 →
Application: 11/173,938 →
Publication: US 2006/0019918
Synergisitic Stimulation of the Immune System Using Immunostimulatory Oligonucleotides and/or Immunomer Compounds in Conjunction with Cytokines and/or Chemotherapeutic Agents or Radiation Therapy
Patent: 7,709,617 →
Application: 11/173,983 →
Publication: US 2006/0217328
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Utilizing Modified Immunostimulatory Dinucleotides
Patent: 7,863,250 →
Application: 11/174,002 →
Publication: US 2006/0211641
Immunostimulatory Oligonucleotide Multimers
Patent: 7,427,405 →
Application: 11/174,282 →
Publication: US 2006/0019919
Immunostimulatory Oligonucleotide Multimers
Patent: 7,498,425 →
Application: 11/174,448 →
Publication: US 2006/0025365
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
Patent: 7,749,975 →
Application: 11/174,450 →
Publication: US 2006/0287262
Immunostimulatory Oligonucleotide Multimers
Patent: 7,498,426 →
Application: 11/234,074 →
Publication: US 2006/0094680
Immunostimulatory Oligonucleotide Multimers
Patent: 7,566,702 →
Application: 11/234,075 →
Publication: US 2006/0094681
Immunostimulatory Oligonucleotide Multimers
Patent: 7,405,285 →
Application: 11/234,396 →
Publication: US 2007/0179103
Antagonist of TLR9-mediated immune response
Application: 60/726,034 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 30, 1993
From: ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 006722/0152 →
Assignment of Assignor's Interest Mar 2, 1995
From: ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 007443/0486 →
Assignment of Assignor's Interest Apr 27, 1995
From: SMITH, LOIS ELAINE HODGSON
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 007455/0498 →
Assignment of Assignor's Interest Apr 27, 1995
From: ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 007455/0492 →
Assignment of Assignor's Interest Jan 16, 1996
From: ROBERTS, PETER C.; FRANK, BRUCE L.; GOODCHILD, JOHN; WOLFE, JIA L.
To: HYBRIDON, INC.
Reel/Frame 007778/0163 →
Assignment of Assignor's Interest Jan 16, 1996
From: FRANK, BRUCE L.; ROBERTS, PETER C.; GOODCHILD, JOHN
To: HYBRIDON, INC.
Reel/Frame 007778/0190 →
Assignment of Assignor's Interest Mar 18, 1996
From: ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 007850/0779 →
Assignment of Assignor's Interest Aug 9, 1996
From: CRAIG, J. CHARLES; MILLS, JOHN S.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 008074/0849 →
Assignment of Assignor's Interest Aug 9, 1996
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 008073/0765 →
Assignment of Assignor's Interest Aug 9, 1996
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 008073/0555 →
Corrective Assignment to Corect Assignor Name Previously Recorded at Reel 8874, Frame 0821. Aug 9, 1996
From: SZYMKOWSKI, DAVID E.; MILLS, JOHN S.; GREENFIELD, ISOBEL; SULLIVAN, VERONICA
To: F. HOFFMAN-LAROCHE AG
Reel/Frame 008594/0256 →
Assignment of Assignor's Interest Aug 9, 1996
From: SZYMOKOWSKI, DAVID E.; MILLS, JOHN S.; GREENFIELD, ISOBEL M.; SULLIVAN, VERONICA
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 008074/0821 →
Assignment of Assignor's Interest Mar 26, 1997
From: SMYTH, ADRIENNE P.; ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 008424/0517 →
Assignment of Assignor's Interest Jun 2, 1997
From: HOFFMANN-LA ROCHE, INC.
To: HYBRIDON, INC.
Reel/Frame 008544/0798 →
Security Interest Jan 29, 1998
From: HYBRIDON, INC.
To: SILICON VALLEY BANK
Reel/Frame 008933/0844 →
Assignment of Assignor's Interest Mar 16, 1998
From: AGRAWAL, SUDHIR; ZHAO, QUIYAN
To: HYBRIDON, INC.
Reel/Frame 009039/0482 →
Assignment of Assignor's Interest Jul 6, 1998
From: ZHANG, RUIWEN
To: HYBRIDON, INC.
Reel/Frame 009300/0007 →
Addendum to Intellectual Property Security Agreement Sep 17, 1998
From: HYBRIDON, INC.
To: SILICON VALLEY BANK
Reel/Frame 009693/0408 →
Assignment of Assignor's Interest Feb 10, 1999
From: HOFFMAN -LA ROCHE INC.
To: HYBRIDON, INC.
Reel/Frame 009767/0600 →
Assignment of Assignor's Interest Feb 16, 1999
From: SZYMKOWSKI, DAVID E.; MILLS, JOHN S.; GREENFIELD, ISOBEL M.; SULLIVAN, VERONICA
To: HYBRIDON, INC.
Reel/Frame 009768/0546 →
Assignment of Assignor's Interest Jun 26, 2000
From: CHEN, JIANDONG; AGRAWAL, SUDHIR
To: HYBRIDON, INC.
Reel/Frame 010930/0137 →
Assignment of Assignor's Interest Sep 12, 2000
From: CHEN, JIANDONG; AGRAWAL, SUDHIR; ZHANG, RUIWEN
To: HYBRIDON, INC.
Reel/Frame 011086/0224 →
Assignment of Assignor's Interest Jan 16, 2001
From: AGRAWAL, SUDHIR
To: HYBRIDON, INC.
Reel/Frame 011440/0669 →
Certificate of Ownership and Merger Sep 29, 2005
From: HYBRIDON INC.
To: IDERA PHARMACEUTICALS, INC.
Reel/Frame 016835/0938 →
Assignment of Assignor's Interest Jan 28, 2008
From: ZHANG, RUIWEN
To: UNIVERSITY OF ALABAMA RESEARCH FOUNDATION, THE
Reel/Frame 020445/0459 →